细胞因子表达检测区分活动性与既往治疗梅毒
该前瞻性队列研究纳入血清固定梅毒患者,采用62种细胞因子多重珠基ELISA检测血清标本,发现脑源性神经营养因子和肿瘤坏死因子β最具预测价值,构建的决策树准确率82.4%,敏感度100%(95%CI 82%-100%),特异度45%(18%-75%),可区分血清固定患者中既往治疗与活动性梅毒。
要点
- 血清细胞因子检测有助于区分血清固定患者的活动性与既往治疗梅毒。
- 脑源性神经营养因子和肿瘤坏死因子β是最具预测价值的细胞因子。
- 决策树模型敏感度100%,但特异度仅45%,需进一步验证。
核心结论
- 基于血清细胞因子的决策树可区分血清固定患者中既往治疗与活动性梅毒的血清标本。
研究设计与样本
- 前瞻性队列研究,纳入接受常规梅毒筛查的个体,主要分析血清固定参与者中既往治疗与活动性梅毒的标本,采用62种细胞因子多重珠基ELISA检测。
主要发现
- 脑源性神经营养因子和肿瘤坏死因子β是最具预测价值的细胞因子。
- 决策树准确率82.4%,敏感度100%(95%CI 82%-100%),特异度45%(18%-75%)。
临床怎么用
- 该检测或可辅助鉴别血清固定患者中活动性与既往治疗梅毒,但特异度有限,需结合临床综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To investigate the role of serum cytokine assays to distinguish between active from treated syphilis among serofast patients, we recruited individuals into a prospective cohort study. Participants underwent routine syphilis screening. We selected specimens from a majority cohort of serofast participants with treated and active syphilis. We analyzed specimens with a 62-cytokine multiplex bead-based enzyme-linked immunosorbent assay. Cytokines, brain-derived neurotrophic factor and tumor necrosis factor β, were most predictive. We built a decision tree that was 82.4% accurate, 100% (95% confidence interval, 82%-100%) sensitive, and 45% (18%-75%) specific. Our decision tree differentiated between serum specimens from serofast participants with treated syphilis versus active syphilis.
引用
- Kojima N, Siebert JC, Maecker H, et al. The Application of Cytokine Expression Assays to Differentiate Active From Previously Treated Syphilis. J Infect Dis. 2020. PMID: 32189000. doi:10.1093/infdis/jiaa127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。